Skip to main content
Premium Trial:

Request an Annual Quote

Schering-Plough Uses GeneMatcher; Paracel's GeneMatcher-Plus Ready

Premium

PASADENA, Calif.--Paracel announced that Schering-Plough Research Institute, the pharmaceutical R&D division of Schering-Plough, has installed its GeneMatcher genomic data analysis system. According to Paracel, GeneMatcher uses an array of optimal algorithms designed for sensitive DNA and protein comparisons to perform sequence homology searches much faster than general-purpose computers. Meanwhile, the company has also released major upgrades to GeneMatcher and introduced four complementary software products designed specifically for automated, high-throughput sequence analysis for pharmaceutical, agricultural, and genomics companies. GeneMatcher-Plus is 50 percent faster than its predecessor and includes support for Smith-Waterman, Hidden-Markov Models, Blast, and double frame algorithms. The four new software packages are: TraceTuner; Sequence Filtering and Masking; EST Clustering and Assembly; and a CAP3 module.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.